RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond
Frontiers in Immunology, ISSN: 1664-3224, Vol: 14, Page: 1114103
2023
- 14Citations
- 17Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations14
- Citation Indexes14
- 14
- CrossRef1
- Captures17
- Readers17
- 17
- Mentions1
- News Mentions1
- News1
Most Recent News
Reports Outline Sepsis Study Findings from China-Japan Friendship Hospital (RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond)
2023 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Blood Daily News -- A new study on sepsis is now available. According
Review Description
Cytokine storms are an important mechanism of sepsis. TNF-α is an important cytokine. As a regulator of TNF superfamily receptors, RIPK1 not only serves as the basis of the scaffold structure in complex I to promote the activation of the NF-κB and MAPK pathways but also represents an important protein in complex II to promote programmed cell death. Ubiquitination of RIPK1 is an important regulatory function that determines the activation of cellular inflammatory pathways or the activation of death pathways. In this paper, we introduce the regulation of RIPK1, RIPK1 PANoptosome’s role in Inflammatory and sepsis, and perspectives.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85153080716&origin=inward; http://dx.doi.org/10.3389/fimmu.2023.1114103; http://www.ncbi.nlm.nih.gov/pubmed/37090690; https://www.frontiersin.org/articles/10.3389/fimmu.2023.1114103/full; https://dx.doi.org/10.3389/fimmu.2023.1114103; https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1114103/full
Frontiers Media SA
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know